Permanently Discontinued

PMS-IMATINIB

PHARMASCIENCE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is PMS-IMATINIB discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that PMS-IMATINIB 400MG has been permanently discontinued (last updated October 27, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is PMS-IMATINIB not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength400MG

Last updated2021-10-27

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

NAT-IMATINIB

NATCO PHARMA (CANADA) INC

400MG · DIN 02397293

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MYLAN-IMATINIB

MYLAN PHARMACEUTICALS ULC

400MG · DIN 02424509

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ IMATINIB

SANDOZ CANADA INCORPORATED

400MG · DIN 02515555

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MINT-IMATINIB

MINT PHARMACEUTICALS INC

400MG · DIN 02492342

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

GLEEVEC

NOVARTIS PHARMACEUTICALS CANADA INC

100MG · DIN 02253275

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

TEVA-IMATINIB

TEVA CANADA LIMITED

100MG · DIN 02399806

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02431122

Strength

400MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

IMATINIB

See all IMATINIB products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2021-11-15

Active Shortage

Disruption of the manufacture of the drug.

2021-10-27

Permanently Discontinued

Business reasons

Other Products from PHARMASCIENCE INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AC&C TABLETS

DIN 02303299

ACET CODEINE 30

DIN 01999648

ACET CODEINE 60

DIN 01999656

ACETAMINOPHEN, CAFFEINE & CODEINE

DIN 02028174

ACETAMINOPHEN, CAFFEINE & CODEINE

DIN 02025337

ARTHRITIS PAIN RELIEF

650MG · DIN 02527901